Cargando…
Takotsubo as Initial Manifestation of Non-Myopathic Cardiomyopathy Due to the Titin Variant c.1489G > T
Background: Whether patients with subclinical cardiomyopathy (CMP) are more prone to experience Takotsubo syndrome (TTS) than patients without CMP, is unknown. We present a patient with TTS as the initial manifestation of a hitherto unrecognized genetic CMP. Method: case report. Results: At age 55 a...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6164847/ https://www.ncbi.nlm.nih.gov/pubmed/30061524 http://dx.doi.org/10.3390/medicines5030080 |
_version_ | 1783359697566302208 |
---|---|
author | Keller, Hans Neuhold, Ulrike Weidinger, Franz Gatterer, Edmund Stöllberger, Claudia Huber, Klaus Finsterer, Josef |
author_facet | Keller, Hans Neuhold, Ulrike Weidinger, Franz Gatterer, Edmund Stöllberger, Claudia Huber, Klaus Finsterer, Josef |
author_sort | Keller, Hans |
collection | PubMed |
description | Background: Whether patients with subclinical cardiomyopathy (CMP) are more prone to experience Takotsubo syndrome (TTS) than patients without CMP, is unknown. We present a patient with TTS as the initial manifestation of a hitherto unrecognized genetic CMP. Method: case report. Results: At age 55 after the unexpected death of her father, a now 61-year-old female had developed precordial pressure. Work-up revealed moderately reduced systolic function, dyskinesia of the interventricular septum, and indications for a TTS. Coronary angiography was normal but ventriculography showed TTS. Cardiac MRI confirmed reduced systolic function and TTS. TTS resolved without treatment and sequelae. At age 57 atrial fibrillation was recorded. After deterioration of systolic function at age 59 dilated CMP was diagnosed. Despite application of levosimendan, sacubitril, valsartan, and ivabradine, complete remission could not be achieved. Upon genetic work-up by means of a gene panel, the heterozygous mutation c.1489G > T (p. E497X) in exon 9 of the titin gene was detected and made responsible for the phenotype. Neurological work-up precluded involvement of the skeletal muscles. The further course was complicated by ventricular arrhythmias, requiring implantation of an implantable cardioverter defibrillator (ICD). Conclusions: previously subclinical CMP may initially manifest as TTS. Since patients with titin CMP are at risk of developing ventricular arrhythmias and thus to experience sudden cardiac death, appropriate anti-arrhythmic therapy needs to be established. |
format | Online Article Text |
id | pubmed-6164847 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-61648472018-10-10 Takotsubo as Initial Manifestation of Non-Myopathic Cardiomyopathy Due to the Titin Variant c.1489G > T Keller, Hans Neuhold, Ulrike Weidinger, Franz Gatterer, Edmund Stöllberger, Claudia Huber, Klaus Finsterer, Josef Medicines (Basel) Case Report Background: Whether patients with subclinical cardiomyopathy (CMP) are more prone to experience Takotsubo syndrome (TTS) than patients without CMP, is unknown. We present a patient with TTS as the initial manifestation of a hitherto unrecognized genetic CMP. Method: case report. Results: At age 55 after the unexpected death of her father, a now 61-year-old female had developed precordial pressure. Work-up revealed moderately reduced systolic function, dyskinesia of the interventricular septum, and indications for a TTS. Coronary angiography was normal but ventriculography showed TTS. Cardiac MRI confirmed reduced systolic function and TTS. TTS resolved without treatment and sequelae. At age 57 atrial fibrillation was recorded. After deterioration of systolic function at age 59 dilated CMP was diagnosed. Despite application of levosimendan, sacubitril, valsartan, and ivabradine, complete remission could not be achieved. Upon genetic work-up by means of a gene panel, the heterozygous mutation c.1489G > T (p. E497X) in exon 9 of the titin gene was detected and made responsible for the phenotype. Neurological work-up precluded involvement of the skeletal muscles. The further course was complicated by ventricular arrhythmias, requiring implantation of an implantable cardioverter defibrillator (ICD). Conclusions: previously subclinical CMP may initially manifest as TTS. Since patients with titin CMP are at risk of developing ventricular arrhythmias and thus to experience sudden cardiac death, appropriate anti-arrhythmic therapy needs to be established. MDPI 2018-07-30 /pmc/articles/PMC6164847/ /pubmed/30061524 http://dx.doi.org/10.3390/medicines5030080 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Case Report Keller, Hans Neuhold, Ulrike Weidinger, Franz Gatterer, Edmund Stöllberger, Claudia Huber, Klaus Finsterer, Josef Takotsubo as Initial Manifestation of Non-Myopathic Cardiomyopathy Due to the Titin Variant c.1489G > T |
title | Takotsubo as Initial Manifestation of Non-Myopathic Cardiomyopathy Due to the Titin Variant c.1489G > T |
title_full | Takotsubo as Initial Manifestation of Non-Myopathic Cardiomyopathy Due to the Titin Variant c.1489G > T |
title_fullStr | Takotsubo as Initial Manifestation of Non-Myopathic Cardiomyopathy Due to the Titin Variant c.1489G > T |
title_full_unstemmed | Takotsubo as Initial Manifestation of Non-Myopathic Cardiomyopathy Due to the Titin Variant c.1489G > T |
title_short | Takotsubo as Initial Manifestation of Non-Myopathic Cardiomyopathy Due to the Titin Variant c.1489G > T |
title_sort | takotsubo as initial manifestation of non-myopathic cardiomyopathy due to the titin variant c.1489g > t |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6164847/ https://www.ncbi.nlm.nih.gov/pubmed/30061524 http://dx.doi.org/10.3390/medicines5030080 |
work_keys_str_mv | AT kellerhans takotsuboasinitialmanifestationofnonmyopathiccardiomyopathyduetothetitinvariantc1489gt AT neuholdulrike takotsuboasinitialmanifestationofnonmyopathiccardiomyopathyduetothetitinvariantc1489gt AT weidingerfranz takotsuboasinitialmanifestationofnonmyopathiccardiomyopathyduetothetitinvariantc1489gt AT gattereredmund takotsuboasinitialmanifestationofnonmyopathiccardiomyopathyduetothetitinvariantc1489gt AT stollbergerclaudia takotsuboasinitialmanifestationofnonmyopathiccardiomyopathyduetothetitinvariantc1489gt AT huberklaus takotsuboasinitialmanifestationofnonmyopathiccardiomyopathyduetothetitinvariantc1489gt AT finstererjosef takotsuboasinitialmanifestationofnonmyopathiccardiomyopathyduetothetitinvariantc1489gt |